Location History:
- Hoboken, NJ (US) (2012)
- London, GB (2009 - 2014)
Company Filing History:
Years Active: 2009-2014
Title: Richard Kelsey: Innovator in Pharmaceutical Composition
Introduction
Richard Kelsey is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target respiratory syncytial virus (RSV). With a total of 3 patents to his name, Kelsey continues to push the boundaries of medical innovation.
Latest Patents
One of Kelsey's latest patents is a pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein. This composition is designed to be highly active against RSV, showcasing its potential in treating viral infections. Another patent focuses on benzodiazepine derivatives that are effective against RSV, detailing a specific formula that includes various chemical components aimed at enhancing therapeutic efficacy.
Career Highlights
Kelsey is currently associated with Arrow Therapeutics Limited, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing treatments for viral infections, particularly those affecting respiratory health.
Collaborations
Throughout his career, Kelsey has collaborated with notable colleagues, including Malcolm Clive Carter and Elisa Henderson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Richard Kelsey stands out as a key figure in pharmaceutical innovation, with a focus on developing effective treatments for RSV. His contributions continue to impact the field positively, paving the way for future advancements in medical science.